###begin article-title 0
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 83 98 <span type="species:ncbi:10090">transgenic mice</span>
Tissue-specific and neural activity-regulated expression of human BDNF gene in BAC transgenic mice
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 351 359 351 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 240 245 <span type="species:ncbi:9606">human</span>
###xml 381 386 <span type="species:ncbi:9606">human</span>
###xml 479 494 <span type="species:ncbi:10090">transgenic mice</span>
###xml 509 514 <span type="species:ncbi:9606">human</span>
###xml 601 606 <span type="species:ncbi:9606">human</span>
Brain-derived neurotrophic factor (BDNF) is a small secreted protein that has important roles in the developing and adult nervous system. Altered expression or changes in the regulation of the BDNF gene have been implicated in a variety of human nervous system disorders. Although regulation of the rodent BDNF gene has been extensively investigated, in vivo studies regarding the human BDNF gene are largely limited to postmortem analysis. Bacterial artificial chromosome (BAC) transgenic mice harboring the human BDNF gene and its regulatory flanking sequences constitute a useful tool for studying human BDNF gene regulation and for identification of therapeutic compounds modulating BDNF expression.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 49 64 <span type="species:ncbi:10090">transgenic mice</span>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 281 286 <span type="species:ncbi:9606">human</span>
###xml 467 482 <span type="species:ncbi:10090">transgenic mice</span>
###xml 584 589 <span type="species:ncbi:9606">human</span>
###xml 795 800 <span type="species:ncbi:10090">mouse</span>
In this study we have generated and analyzed BAC transgenic mice carrying 168 kb of the human BDNF locus modified such that BDNF coding sequence was replaced with the sequence of a fusion protein consisting of N-terminal BDNF and the enhanced green fluorescent protein (EGFP). The human BDNF-BAC construct containing all BDNF 5' exons preceded by different promoters recapitulated the expression of endogenous BDNF mRNA in the brain and several non-neural tissues of transgenic mice. All different 5' exon-specific BDNF-EGFP alternative transcripts were expressed from the transgenic human BDNF-BAC construct, resembling the expression of endogenous BDNF. Furthermore, BDNF-EGFP mRNA was induced upon treatment with kainic acid in a promotor-specific manner, similarly to that of the endogenous mouse BDNF mRNA.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 200 215 <span type="species:ncbi:10090">transgenic mice</span>
###xml 305 310 <span type="species:ncbi:10090">mouse</span>
###xml 315 320 <span type="species:ncbi:9606">human</span>
###xml 359 364 <span type="species:ncbi:9606">human</span>
Genomic region covering 67 kb of human BDNF gene, 84 kb of upstream and 17 kb of downstream sequences is sufficient to drive tissue-specific and kainic acid-induced expression of the reporter gene in transgenic mice. The pattern of expression of the transgene is highly similar to BDNF gene expression in mouse and human. This is the first study to show that human BDNF gene is regulated by neural activity.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 42 43 42 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
Brain-derived neurotrophic factor (BDNF) [1], a member of the neurotrophin family, promotes survival and differentiation of several neuronal populations during mammalian development [2,3]. In the adult central nervous system, BDNF acts as a regulator of activity-dependent neurotransmission and plasticity [4] and promotes survival of newborn hippocampal neurons [5]. BDNF has widespread expression in the developing and adult mammalian nervous system, its mRNA and protein levels rising dramatically in postnatal development [6-10]. In the adult, BDNF is also expressed in a number of non-neural tissues, with the highest levels of BDNF mRNA detected in thymus, heart and lung [11,12].
###end p 9
###begin p 10
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1027 1029 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 127 130 <span type="species:ncbi:10116">rat</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 497 502 <span type="species:ncbi:9606">human</span>
###xml 828 833 <span type="species:ncbi:9606">human</span>
###xml 984 989 <span type="species:ncbi:9606">human</span>
BDNF gene has a complex structure with multiple untranslated 5' exons alternatively spliced to one protein-coding 3' exon. The rat BDNF gene structure initially described to contain five exons [13] has been recently updated with a number of newly discovered exons for rodent [14,15] and human [16,17] BDNF. Untranslated 5' exons are linked with differentially regulated promoters directing tissue-specific expression of BDNF [13-17]. Furthermore, recently discovered BDNF antisense transcripts in human may exert additional control over BDNF transcription [16,17]. BDNF is a neural activity-dependent gene in rodents: various physiological stimuli induce its expression in neurons through excitatory neurotransmission-triggered calcium influx [18,19]. However, no data is available about activity-dependent transcription of the human BDNF gene in neurons, except one report showing that dopamine signaling increases the levels of BDNF exon IV transcripts in neuronally differentiated human embryonic teratocarcinoma NT2 cells [20].
###end p 10
###begin p 11
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 625 632 625 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 938 946 938 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 950 952 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1072 1075 1072 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1179 1181 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1340 1342 1340 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 279 294 <span type="species:ncbi:10090">transgenic mice</span>
###xml 625 632 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 861 876 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 955 960 <span type="species:ncbi:10090">Mouse</span>
###xml 976 979 <span type="species:ncbi:10116">rat</span>
###xml 1203 1218 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1238 1243 <span type="species:ncbi:9606">human</span>
Alterations in BDNF function have been associated with a variety of disorders of the nervous system [2]. As therapies modulating neurotrophic activity are being actively sought [21], it is of great importance to create model systems for studying the regulation of BDNF gene. BAC transgenic mice have proven useful in studying gene regulation as a) BAC clones are often long enough to contain all necessary DNA elements to recapitulate the expression patterns of endogenous genes independent of host genomic sequences flanking the transgene integration site and b) they can be easily modified with homologous recombination in E. coli, e.g. to introduce reporter genes under the control of promoters of interest [22]. BAC transgenes with EGFP reporter gene have been used for characterization of expression and regulatory regions of several neural genes [23-25]. Transgenic mice have been generated previously to study BDNF gene regulation in vivo [26,27]. Mouse lines carrying rat BDNF sequences of 10 kb range recapitulated BDNF expression only partially, suggesting that cis-acting regulatory elements necessary for accurate control of BDNF expression are located further away [26]. Recently, YAC-BDNF transgenic mice carrying 145 kb of human BDNF locus with BDNF coding sequence substituted for the EGFP reporter gene have been reported [27].
###end p 11
###begin p 12
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 436 443 436 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 36 51 <span type="species:ncbi:10090">transgenic mice</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 142 147 <span type="species:ncbi:9606">human</span>
###xml 719 734 <span type="species:ncbi:10090">transgenic mice</span>
In this study we have generated BAC transgenic mice carrying human BDNF-EGFP fusion (hBDNF-EGFP) reporter gene under the control of 168 kb of human BDNF genomic sequences. C-terminal addition of EGFP to BDNF protein has been shown not to affect BDNF cellular localization, secretion and activation of its receptor TrkB in cultured neurons [28-30]. Therefore, to enable studying subcellular localization of the hBDNF-EGFP fusion protein in vivo, we specifically produced this fusion reporter gene construct. The aims of the study were to investigate a) expression of hBDNF-EGFP mRNA and protein in the brain and non-neural tissues and b) activity-dependent regulation of the hBDNF-EGFP transgene in the brain of the BAC transgenic mice.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
Generation of transgenic mice with 169 kb hBDNF-EGFP-BAC
###end title 14
###begin p 15
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A&#8211;C</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 989 991 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 130 145 <span type="species:ncbi:10090">transgenic mice</span>
###xml 564 579 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 1093 1098 <span type="species:ncbi:10090">mouse</span>
A 168 kb BAC clone extending 84 kb upstream and 17 kb downstream of human BDNF gene was used to generate human BDNF-EGFP reporter transgenic mice (see Materials and Methods and Figure 1A-C). Briefly, EGFP reporter gene was inserted in-frame with BDNF coding region replacing the BDNF stop codon (Figure 1C). Resulting hBDNF-EGFP fusion protein was expected to mimic subcellular localization of endogenous BDNF, allowing fine resolution of transgene expression. hBDNF-EGFP-BAC construct was tested for integrity using PCR and restriction analysis (data not shown). Transgenic mice were generated by pronuclear injection, yielding four transgenic founders (A4, E1, E4 and C3). All founders contained one to two transgene copies as estimated by slot-blot hybridization (Figure 1D). PCR analysis of C3 genomic DNA and sequencing of the PCR products revealed tandem integration of two transgene copies and confirmed the intactness of 5' and 3' end sequences of the integrated transgene (Figure 1E). Offspring was obtained from three founders and bred for several generations to generate transgenic mouse lines E1, E4 and C3.
###end p 15
###begin p 16
###xml 0 101 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Schematic drawings of rodent and human BDNF genes and the BAC transgenic construct used in this study</bold>
###xml 111 112 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 125 126 125 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 781 782 781 782 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1139 1140 1139 1140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1403 1404 1403 1404 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 484 489 <span type="species:ncbi:9606">human</span>
###xml 649 654 <span type="species:ncbi:9606">human</span>
###xml 866 871 <span type="species:ncbi:9606">human</span>
###xml 1043 1048 <span type="species:ncbi:9606">human</span>
###xml 1233 1237 <span type="species:ncbi:10090">mice</span>
###xml 1391 1396 <span type="species:ncbi:10090">mouse</span>
###xml 1450 1455 <span type="species:ncbi:10090">mouse</span>
###xml 1551 1556 <span type="species:ncbi:10090">mouse</span>
Schematic drawings of rodent and human BDNF genes and the BAC transgenic construct used in this study. Rodent (A) and human (B) BDNF gene structures. Rodent BDNF gene consists of a number of 5' exons (I-VIII) spliced together with a common protein-coding sequence in exon IX (transcriptional start sites are indicated with arrows). BDNF transcription can also start from exon IX introducing a unique 5' UTR sequence. Hatched lines indicate sites of alternative splicing. Although the human BDNF gene has a similar structure and splicing pattern, it has additional exons Vh and VIIIh, longer and more complexly spliced 5'UTR of exon IX. Furthermore, human BDNF exons VIII and VIIIh are not used as 5'exons, but are always spliced with exon V. For detailed description see [14,16]. (C) Schematic drawing of the modified BAC construct used in this study containing the human BDNF locus. EGFP reporter gene was inserted in-frame with the BDNF coding region before the BDNF stop codon creating a fused BDNF-EGFP open reading frame within 168 kb of human BDNF locus. Arrows P1-3 indicate PCR primers used for analysis of transgene integration. (D) Slot-blot hybridization analysis of transgene copy number in hBDNF-EGFP transgenic founder mice (A4, C3, E1 and E4). BAC standard contains hBDNF-EGFP-BAC DNA in amounts equivalent to 1-3 copies of transgene in the blotted genomic DNA. WT- wild type mouse DNA. (E) PCR analysis of genomic DNA from transgenic mouse line C3 with primers detecting tandem integration of hBDNF-EGFP-BAC constructs. WT - wild type mouse DNA as a negative control; (+) - circular hBDNF-EGFP-BAC DNA as a positive control; (-) - PCR without DNA as a negative control.
###end p 16
###begin title 17
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Expression of hBDNF-EGFP in transgenic mouse tissues
###end title 17
###begin p 18
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 955 956 955 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 609 614 <span type="species:ncbi:10090">mouse</span>
###xml 619 624 <span type="species:ncbi:9606">human</span>
###xml 674 679 <span type="species:ncbi:10090">mouse</span>
###xml 860 865 <span type="species:ncbi:10090">mouse</span>
###xml 941 946 <span type="species:ncbi:9606">human</span>
From three transgenic founder lines, C3 line showed pattern of expression of hBDNF-EGFP mRNAs that was highly similar to the expression of mouse endogenous BDNF (mBDNF) mRNA (Figure 2A). RT-PCR analysis revealed relatively high transgene expression in all brain regions of C3 mice, including cerebral cortex, hippocampus, striatum, thalamus, hypothalamus, midbrain, pons, medulla and cerebellum. In non-neural tissues, high levels of transgene mRNA were detected in testis, moderate levels in thymus and lung and low levels in skeletal muscle. BDNF mRNA is endogenously expressed in all these tissues both in mouse and human [14,16]; (Figure 2A). However, dissimilarly from mouse endogenous BDNF mRNA, hBDNF-EGFP mRNA was not detected in heart and kidney, where relatively high levels of mBDNF mRNA were detected. Low expression of hBDNF-EGFP transgene in the mouse kidney correlates with the finding that BDNF is expressed at low levels in human kidney [8,16].
###end p 18
###begin p 19
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">hBDNF-EGFP mRNA expression in tissues of three transgenic mouse lines</bold>
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 301 304 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cx </italic>
###xml 314 317 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hc </italic>
###xml 332 335 332 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">St </italic>
###xml 347 350 347 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Th </italic>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mb </italic>
###xml 377 380 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PM </italic>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cb </italic>
###xml 413 416 413 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ty </italic>
###xml 426 429 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">He </italic>
###xml 438 441 438 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lu </italic>
###xml 449 452 449 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Li </italic>
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ki </italic>
###xml 474 477 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM </italic>
###xml 496 499 496 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp </italic>
###xml 509 512 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Te </italic>
###xml 523 524 523 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 791 793 791 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 816 821 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tRNA </italic>
###xml 835 838 835 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HC </italic>
###xml 853 856 853 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CX </italic>
###xml 974 975 974 975 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 156 161 <span type="species:ncbi:10090">mouse</span>
###xml 190 195 <span type="species:ncbi:10090">mouse</span>
###xml 210 215 <span type="species:ncbi:9606">human</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 578 583 <span type="species:ncbi:10090">mouse</span>
###xml 735 740 <span type="species:ncbi:10090">mouse</span>
###xml 745 750 <span type="species:ncbi:9606">human</span>
###xml 823 828 <span type="species:ncbi:4932">yeast</span>
###xml 1032 1037 <span type="species:ncbi:10090">mouse</span>
###xml 1111 1116 <span type="species:ncbi:9606">human</span>
###xml 1169 1174 <span type="species:ncbi:9606">human</span>
###xml 1185 1190 <span type="species:ncbi:10090">mouse</span>
hBDNF-EGFP mRNA expression in tissues of three transgenic mouse lines. (A) RT-PCR analysis of hBDNF-EGFP mRNA expression in tissues of three transgenic BAC mouse lines - C3, E1, E4. mBDNF - mouse BDNF; hBDNF - human BDNF in human tissues; HPRT - reference gene hypoxanthine phosphoribosyltransferase. Cx - cortex; Hc - hippocampus; St - striatum; Th - thalamus; Mb - midbrain; PM - pons/medulla; Cb - cerebellum; Ty - thymus; He - heart; Lu - lung; Li - liver; Ki - kidney; SM - skeletal muscle; Sp - spleen; Te - testis. (B) Analysis of hBDNF-EGFP mRNA expression levels in C3 mouse brain by RNase protection assay. hBDNF-EGFP probe was used to determine both transgenic and endogenous BDNF mRNA levels as protein coding sequences of mouse and human BDNF share a high degree of similarity. P - probe without RNase; tRNA - yeast tRNA; HC - hippocampus; CX - cortex. On the right, black boxes denote vector-derived sequences, white boxes BDNF and gray boxes EGFP sequences. (C) Expression of alternative hBDNF-EGFP transcripts in C3 mouse hippocampus (HC), analyzed by RT-PCR. PCR primers used were specific for human BDNF transcripts as shown by control reactions with human (hHC) and mouse (mHC) hippocampal cDNA. eIX - transcript containing 5'-extended exon IX.
###end p 19
###begin p 20
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
In E1 mice, transgene expression recapitulated that of the endogenous BDNF mRNA in thymus, lung, kidney and testis, but not in other non-neural tissues that express BDNF. In the adult brain of E1 mice, transgene mRNA expression was detected in midbrain, cerebellum, pons and medulla at levels that were lower than in the respective brain regions of C3 mice. In E4 line, hBDNF-EGFP mRNA was detected only in testis and thymus (Figure 2A).
###end p 20
###begin p 21
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 483 488 <span type="species:ncbi:9606">human</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
Expression of transgenic hBDNF-EGFP mRNA was further examined in different brain regions of C3 mice since this line largely recapitulated endogenous BDNF expression and expressed the transgene at the highest levels. Quantification of hBDNF-EGFP transcripts in C3 hippocampus and cortex using ribonuclease protection assay (RPA) revealed that transgene mRNA levels were about tenfold lower than endogenous mBDNF mRNA levels (Figure 2B). Analysis of transcription from the alternative human BDNF promoters in C3 mice confirmed the expression of all transcripts with different 5' exons described to date (exons I-IXe) both in hippocampus (Figure 2C) and cerebral cortex (data not shown).
###end p 21
###begin p 22
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 526 534 526 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 676 684 676 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1004 1009 1004 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C, D</xref>
###xml 1021 1025 1021 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4K&#8211;N</xref>
###xml 1159 1164 1159 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3G, H</xref>
###xml 1176 1181 1176 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C, D</xref>
###xml 1417 1422 1417 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3G, H</xref>
###xml 1434 1439 1434 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E, F</xref>
###xml 1588 1593 1588 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3G, H</xref>
###xml 1605 1610 1605 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4I, J</xref>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
In situ hybridization of C3 mice adult brain sections revealed hBDNF-EGFP mRNA expression in the hippocampus, particularly in the pyramidal neurons of CA1 and CA3 regions and in the polymorphic neurons in the hilus of the dentate gyrus, and also in several cortical areas, including neurons of frontal, sensorimotor and piriform cortex (Figure 3, 4). Endogenous mBDNF mRNA was detected in all brain areas where hBDNF-EGFP mRNA labeling was observed. However, hBDNF-EGFP labeling was absent or below the detection limit of our in situ hybridization assay in several areas expressing mBDNF mRNA, e.g. claustrum, amygdala, thalamic, hypothalamic and pontine nuclei. Furthermore, in situ hybridization showed differential expression of hBDNF and mBDNF in cortical and hippocampal subfields. While mBDNF mRNA was expressed at high levels throughout the cerebral cortex, hBDNF-EGFP labeling was more prominent in the frontal cortex and in the sensorimotor area extending along the longitudinal fissure (Figure 3C, D and Figure 4K-N). In the hippocampus, hBDNF-EGFP labeling was observed over the CA1 and hilar subfields and part of the CA3 subfield (CA3b in Figure 3G, H and Figure 4C, D), mimicking the pattern of expression of endogenous mBDNF mRNA. On the other hand, hBDNF-EGFP mRNA was expressed at considerably lower levels in the part of CA3 subfield that showed high levels of mBDNF mRNA expression (CA3a in Figure 3G, H and Figure 4E, F). In addition, no hBDNF-EGFP labeling was detected in the granule neurons of dentate gyrus where endogenous mBDNF mRNA was highly expressed (Figure 3G, H and Figure 4I, J).
###end p 22
###begin p 23
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overlapping patterns of BAC-driven hBDNF-EGFP and mBDNF mRNA expression in C3 mouse brain</bold>
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 173 174 172 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 175 176 174 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 191 192 190 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 193 194 192 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 207 208 206 207 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 215 216 214 215 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 257 258 256 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 265 266 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 321 322 320 321 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 329 330 328 329 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 384 387 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FC </italic>
###xml 404 407 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM </italic>
###xml 430 433 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HC </italic>
###xml 448 451 447 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pn </italic>
###xml 469 473 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hth </italic>
###xml 489 492 488 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cg </italic>
###xml 512 516 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pir </italic>
###xml 535 538 534 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cl </italic>
###xml 551 555 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Str </italic>
###xml 567 576 566 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CA1, CA3 </italic>
###xml 601 604 600 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DG </italic>
###xml 636 639 635 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 670 673 669 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Th </italic>
###xml 685 689 684 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amy </italic>
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Overlapping patterns of BAC-driven hBDNF-EGFP and mBDNF mRNA expression in C3 mouse brain. In situ hybridization analysis, photoemulsion autoradiographs of 16 mum sagittal (A,B) and coronal (C-H) sections. (C) and (D) are sections taken at striatal level; (E) and (F) are sections taken at posterior hippocampal levels; (G) and (H) show enlarged hippocampal area (scale bar: 0,5 mm). FC - frontal cortex;SM - sensorimotor cortex; HC - hippocampus; Pn - pontine nuclei; Hth - hypothalamus; Cg - cingulate cortex; Pir - piriform cortex; Cl - claustrum; Str - striatum; CA1, CA3 - hippocampal subfields; DG - dentate gyrus of hippocampus; Hi - hilar area of dentate gyrus; Th - thalamus; Amy - amygdala.
###end p 23
###begin p 24
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cellular expression of hBDNF-EGFP mRNA in adult C3 mouse brain</bold>
###xml 64 72 64 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 405 414 405 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CA1, CA3 </italic>
###xml 439 442 439 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DG </italic>
###xml 474 477 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 508 511 508 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FC </italic>
###xml 529 532 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM </italic>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pir </italic>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Cellular expression of hBDNF-EGFP mRNA in adult C3 mouse brain. In situ hybridization analysis, shown are bright-field autoradiographs of emulsion-dipped sections. Hybridization probes are indicated above the columns. Filled arrowhead indicates a neuron with strong labeling, empty arrowhead indicates a neuron with weak or absent labeling and double arrowheads indicate a glial cell showing no labeling. CA1, CA3 - hippocampal subfields; DG - dentate gyrus of hippocampus; Hi - hilar area of dentate gyrus; FC - frontal cortex; SM - sensorimotor cortex; Pir - piriform cortex. Scale bar: 20 mum.
###end p 24
###begin p 25
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 512 517 512 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B, C</xref>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 687 692 <span type="species:ncbi:9606">human</span>
Since the BDNF gene in the transgenic construct was of human origin, we also analyzed the expression of BDNF in the human hippocampus using in situ hybridization. In agreement with earlier findings [31,32], our results showed that the highest levels of hBDNF mRNA were present in the granule cells of dentate gyrus, whereas other hippocampal regions showed relatively weaker expression (Figure 5). However, strong hBDNF labeling was detected over majority of CA3 and CA1 neurons using high magnification (Figure 5B, C), indicating that these areas show much weaker signal in the dark-field image partly because of the scarcity of neuronal cell bodies in the CA1 and CA3 subfields of the human hippocampus.
###end p 25
###begin p 26
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of BDNF mRNA in the human hippocampus</bold>
###xml 51 52 51 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 119 122 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DG </italic>
###xml 157 160 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 191 195 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sub </italic>
###xml 208 217 207 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CA1, CA3 </italic>
###xml 243 246 242 245 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B-E</bold>
###xml 353 354 352 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 365 366 364 365 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 380 381 379 380 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 420 421 419 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 31 36 <span type="species:ncbi:9606">human</span>
Expression of BDNF mRNA in the human hippocampus. (A) In situ hybridization autoradiograph of a 16 mum coronal section.DG - granular layer of dentate gyrus; Hi - hilar area of dentate gyrus; Sub - subiculum; CA1, CA3 - hippocampal subfields. (B-E) High magnification bright-field photomicrographs of hematoxylin-counterstained neurons in subfields CA1 (B) and CA3 (C), the hilus (D) and granular layer of dentate gyrus (E). Filled arrowhead indicates a neuron with strong labeling, empty arrowhead indicates a neuron with weak or absent labeling and double arrowheads indicate a glial cell showing no labeling.
###end p 26
###begin p 27
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
Next we examined expression of hBDNF-EGFP fusion protein across tissues in C3 mice. No EGFP fluorescence was observed in brain sections or cultured primary embryonic (E18) hippocampal neurons. In addition, hBDNF-EGFP protein was not detected in the hippocampus, cortex and testis by Western blot analysis with anti-EGFP or anti-BDNF antibodies (data not shown). hBDNF-EGFP open reading frame in C3 genomic DNA was analyzed for possible mutations by sequencing and was found to be intact. Together with mRNA expression data these results suggest that hBDNF-EGFP protein was either not translated in the brain and testis of C3 mice or was expressed at levels below the detection limits of our methods.
###end p 27
###begin title 28
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Kainic acid induces hBDNF-EGFP mRNA expression in transgenic mouse brain
###end title 28
###begin p 29
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 404 409 <span type="species:ncbi:10090">mouse</span>
###xml 646 651 <span type="species:ncbi:9606">human</span>
###xml 718 733 <span type="species:ncbi:10090">transgenic mice</span>
Kainic acid (KA), agonist of the KA subtype ionotropic glutamate receptor, has been shown to induce BDNF mRNA levels in adult rodent hippocampus and cerebral cortex [13,19,33,34]. KA induction of transgenic hBDNF-EGFP transcripts in the hippocampus and cerebral cortex of C3 mice largely followed the induction pattern of endogenous mBDNF transcripts (Figure 6A). KA markedly upregulated both endogenous mouse and transgenic hBDNF-EGFP transcripts containing exons I, IV and 5'-extended exon IX (eIX) in the hippocampus and cortex. hBDNF-EGFP and mBDNF mRNAs containing other 5' exons were induced to a lesser extent. Of note, recently described human-specific exon Vh-containing transcripts were not induced by KA in transgenic mice in the context of 169 kb hBDNF-EGFP BAC construct (Figure 6A).
###end p 29
###begin p 30
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kainic acid (30 mg/kg) induces transgenic hBDNF-EGFP mRNA expression in brains of C3 line transgenic mice</bold>
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 416 417 416 417 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 592 593 592 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 595 603 595 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pir </italic>
###xml 692 701 692 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CA1, CA3 </italic>
###xml 726 729 726 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DG </italic>
###xml 761 764 761 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 795 798 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Th </italic>
###xml 810 814 810 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hth </italic>
###xml 830 834 830 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amy </italic>
###xml 90 105 <span type="species:ncbi:10090">transgenic mice</span>
###xml 175 180 <span type="species:ncbi:10090">mouse</span>
###xml 255 260 <span type="species:ncbi:10090">mouse</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 639 644 <span type="species:ncbi:10090">mouse</span>
Kainic acid (30 mg/kg) induces transgenic hBDNF-EGFP mRNA expression in brains of C3 line transgenic mice. (A) Induction of alternatively spliced hBDNF-EGFP transcripts in C3 mouse hippocampus (HC) and cerebral cortex (CTX), analyzed with RT-PCR. mBDNF - mouse transcripts; ND - not determined; KA - kainic acid treated mice; CTR - control mice. Three BDNF-II bands correspond to alternatively spliced transcripts. (B) Quantitative real-time RT-PCR analysis of selected BDNF transcripts, normalized to HPRT1 levels and expressed as fold difference relative to mRNA levels in untreated mice. (C) In situ hybridization autoradiographs of C3 mouse coronal brain sections. Pir - piriform cortex; CA1, CA3 - hippocampal subfields; DG - dentate gyrus of hippocampus; Hi - hilar area of dentate gyrus; Th - thalamus; Hth - hypothalamus; Amy - amygdala.
###end p 30
###begin p 31
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
Levels of BDNF transcripts showing the most robust induction by kainic acid were analyzed further using quantitative real-time RT-PCR analysis (Figure 6B). Transgenic hBDNF-EGFP exon I, exon IV and 5'-extended exon IX transcripts, and total hBDNF-EGFP mRNA were potently induced in both hippocampus and cortex following 3 hours of kainate treatment, similarly to respective endogenous mBDNF mRNAs. Exon VI-containing hBDNF-EGFP and endogenous mBDNF transcripts showed no induction, which is consistent with previous findings [13,14,33].
###end p 31
###begin p 32
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
In situ hybidization analysis showed marked induction of transgenic hBDNF-EGFP mRNA by KA in the pyramidal neurons of CA1-CA3 layers, in the hilar region of hippocampus and also in the layers II - VI of cerebral cortex (Figure 6C). Importantly, kainic acid induced transgene expression also in the granular layer of dentate gyrus of hippocampus, whereas control animals did not show any detectable expression in this area. Endogenous mBDNF was induced in the same neuronal populations, suggesting that the 169 kb hBDNF-EGFP BAC construct contains all the regulatory elements that mediate kainic acid induction. We also examined expression of the hBDNF-EGFP protein in the brains of kainic acid treated C3 mice by direct EGFP fluorescence and Western blot analysis but no fusion protein was detected (data not shown).
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 1179 1181 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 19 34 <span type="species:ncbi:10090">transgenic mice</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 221 226 <span type="species:ncbi:9606">human</span>
###xml 329 334 <span type="species:ncbi:9606">human</span>
###xml 633 638 <span type="species:ncbi:9606">human</span>
In this study, BAC transgenic mice carrying 168 kb of the human BDNF locus and encoding human BDNF-EGFP fusion protein were generated and analyzed. Out of three analyzed founder lines, one line (C3) largely recapitulated human BDNF mRNA expression in the brain, thymus, lung, skeletal muscle and testis. Founder line E1 mimicked human BDNF mRNA expression in some brain regions, and also in thymus, lung and kidney. Founder line E4 expressed transgene only in the thymus and testis. These results showed that although all three founder lines expressed hBDNF-EGFP mRNA at different levels, the 169 kb BAC construct, carrying 67 kb of human BDNF gene, 84 kb of 5' and 17 kb of 3' sequences, contains regulatory elements necessary for hBDNF mRNA expression in many brain regions and non-neural tissues. However, integration site-dependent expression of transgene in different founder lines suggests that the BAC construct may not contain necessary insulator elements to protect it from the influence of genomic regions flanking the transgene integration site. It has been shown for many genes that insulators can functionally isolate neighboring genes and block their interactions [35].
###end p 34
###begin p 35
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1051 1053 1051 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1335 1336 1335 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1337 1339 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1340 1342 1340 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1343 1345 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 187 192 <span type="species:ncbi:10090">mouse</span>
###xml 377 382 <span type="species:ncbi:10090">mouse</span>
###xml 387 392 <span type="species:ncbi:9606">human</span>
###xml 636 641 <span type="species:ncbi:9606">human</span>
###xml 771 776 <span type="species:ncbi:9606">human</span>
###xml 803 808 <span type="species:ncbi:9606">human</span>
###xml 935 940 <span type="species:ncbi:10090">mouse</span>
###xml 1119 1124 <span type="species:ncbi:9606">human</span>
###xml 1129 1134 <span type="species:ncbi:10090">mouse</span>
###xml 1316 1321 <span type="species:ncbi:9606">human</span>
In several non-neural tissues, the 169 kb hBDNF-EGFP BAC recapitulated endogenous expression of both mouse and human BDNF. Transgenic mRNA was expressed in the thymus and testis in three mouse lines, expression in the lung was seen in two lines and only one line expressed hBDNF-EGFP in the kidney and skeletal muscle. All these tissues have been shown to express BDNF both in mouse and human [7,14,16]. Of note, all three founder lines expressed relatively high levels of hBDNF-EGFP in adult testis, in contrast to the very low expression levels of endogenous mBDNF in the testis. This transgene expression pattern can be explained by human origin of the BDNF gene as relatively high levels of BDNF mRNA, comparable to the levels in the brain, have been detected in the human testis [16]. In the adult human testis, expression of BDNF and its receptor TrkB has been reported in Leydig, Sertoli and germ cells [36], while in the adult mouse testis, BDNF expression has been detected in Sertoli cells and expression of its receptor TrkB in germ cells [37]. These findings indicate differences in BDNF expression between human and mouse and are further supported by the present study. On the other hand, none of the founder lines expressed hBDNF mRNA in the heart, a tissue with high levels of BDNF expression both in human and rodents [8,11,12,14]. This suggests that distinct heart-specific regulatory elements are located outside of the genomic DNA fragment that was included in the BAC construct.
###end p 35
###begin p 36
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 569 577 569 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 696 704 696 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
###xml 463 468 <span type="species:ncbi:9606">human</span>
Detailed analysis of hBDNF-EGFP expression in the C3 mouse brain by in situ hybridization showed that the transgene mimicked mBDNF expression in many neuron populations, including neurons of the CA1-CA3 and hilar regions of the hippocampus and the cerebral cortex. However, hBDNF-EGFP failed to recapitulate endogenous BDNF expression in several neuron populations, including the granule cells of dentate gyrus of hippocampus where BDNF mRNA is expressed both in human and rodents. hBDNF-EGFP expression was detected in all analyzed brain regions by RT-PCR, but not by in situ hybridization, indicating that transgene mRNA levels in several brain structures were below the detection limit of our in situ hybridization analysis.
###end p 36
###begin p 37
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 845 852 845 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1416 1424 1416 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 2048 2050 2048 2050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 2144 2146 2144 2146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 2195 2197 2195 2197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 2198 2200 2198 2200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 2461 2469 2461 2469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 2548 2550 2548 2550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
###xml 390 393 <span type="species:ncbi:10116">rat</span>
###xml 708 713 <span type="species:ncbi:10090">mouse</span>
###xml 718 721 <span type="species:ncbi:10116">rat</span>
###xml 829 834 <span type="species:ncbi:9606">human</span>
###xml 1110 1113 <span type="species:ncbi:10116">rat</span>
###xml 1231 1236 <span type="species:ncbi:10090">mouse</span>
###xml 1464 1469 <span type="species:ncbi:10090">mouse</span>
###xml 1670 1675 <span type="species:ncbi:9606">human</span>
###xml 1803 1808 <span type="species:ncbi:9606">human</span>
###xml 1895 1898 <span type="species:ncbi:10116">rat</span>
###xml 2330 2335 <span type="species:ncbi:9606">human</span>
###xml 2375 2390 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 2445 2450 <span type="species:ncbi:9606">human</span>
BDNF transcription is regulated by neuronal activity through calcium-mediated pathways [18,38]. Systemic treatment of rodents with kainic acid (KA) has been used to model activity-dependent induction of BDNF mRNA in the nervous system [13,19,33,34]. Here we show that KA differentially induced alternative hBDNF-EGFP transcripts in the cortex and hippocampus (for comparison with mouse and rat see Table 1). Pronounced induction of transgenic hBDNF-EGFP transcripts containing exons I, IV, and 5'-extended exon IX (eIX), moderate induction of transcripts containing exons II, III and absence of induction of transcripts containing exon VI is consistent with the induction pattern of respective BDNF mRNAs in mouse and rat [13,14,33]. To our knowledge, this is the first time to report neural activity-dependent regulation of the human BDNF gene in vivo. Real-time PCR showed that total transgenic mRNA, as well as transcripts containing exons I, IV and 5'-extended exon IX were induced to a lesser extent than the respective endogenous mBDNF mRNAs. This is consistent with earlier results reported for shorter rat BDNF transgenes [26] and could be caused by increased stability of transgenic BDNF-reporter mRNAs as compared to the mouse endogenous BDNF mRNAs. Alternatively, the absence of important regulatory elements in the transgenic construct may underlie the reduced induction of the transgene by kainic acid. In situ hybridization analysis of KA-treated C3 mouse brains showed induction of hBDNF-EGFP mRNAs in several neuronal populations where endogenous BDNF mRNA levels were also increased. These results show that, similarly to rodent BDNF, expression of the human BDNF gene is induced by neural activity and that regulatory elements mediating the induction are included in the 168 kb of the human BDNF locus contained in the BAC transgene. Several regulatory elements located in the rat BDNF proximal promoter IV and the transcription factors mediating activity-dependent activation of this promoter have previously been characterized [39]. Among these elements, CRE (cAMP-response element) was found to be the most important for Ca2+-mediated activation of rodent BDNF promoter IV [40-42]. However, the respective regulatory elements and transcription factors responsible for the activity-dependent regulation of the human BDNF gene have not been characterized. Transgenic mice described here can be used to study the regulation of human BDNF gene in vivo using a variety of methods successfully applied in the studies of rodent BDNF [39].
###end p 37
###begin p 38
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 31 34 <span type="species:ncbi:10116">rat</span>
Regulation of human, mouse and rat BDNF exon-specific mRNAs by kainic acid in the hippocampus and cerebral cortex.
###end p 38
###begin p 39
###xml 160 164 160 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1,2 </sup>
###xml 202 204 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
- no induction; * weak induction; ** strong induction; ND - not determined; X - transcript containing this exon as the 5' exon does not exist in this organism; 1,2 based on data from the present study; 3 based on data from [14]; HC - hippocampus; CTX - cerebral cortex.
###end p 39
###begin p 40
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 361 369 361 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1336 1338 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 12 27 <span type="species:ncbi:10090">transgenic mice</span>
###xml 120 124 <span type="species:ncbi:10090">Mice</span>
###xml 187 190 <span type="species:ncbi:10116">rat</span>
###xml 515 518 <span type="species:ncbi:10116">rat</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
###xml 966 969 <span type="species:ncbi:10116">rat</span>
###xml 1202 1207 <span type="species:ncbi:10090">mouse</span>
###xml 1319 1334 <span type="species:ncbi:10090">transgenic mice</span>
Previously, transgenic mice carrying shorter fragments of the BDNF locus have been generated and characterized [26,27]. Mice expressing the CAT reporter gene under the control of 9 kb of rat BDNF genomic sequences covering promoters I-III or promoters IV-VI showed relatively high CAT activity in most tissues and brain regions expressing endogenous BDNF mRNA. In situ hybridization analysis showed that these constructs carrying either BDNF promoters I-III or IV-VI were able to drive CAT mRNA expression in adult rat brain in a pattern largely overlapping with mouse BDNF mRNA expression. Nevertheless, recapitulation of endogenous BDNF expression had a number of shortcomings in these transgenes: both constructs were not expressed or were expressed at low levels in the dentate granule cells and granule cells of cerebellum; BDNF IV-VI did not mimic BDNF expression in the heart; both constructs displayed relatively high reporter activity in the striatum where rat BDNF is virtually not expressed [43]. It was assumed that these transgenic constructs lacked important regulatory elements, which could be present in a much longer gene fragment than the BAC clone used here. Although BAC transgenic mouse lines generated in this study showed improved recapitulation of expression as compared to that of the BDNF-CAT transgenic mice [26], we could not detect transgene expression in several tissues and neuron populations that express endogenous BDNF mRNA.
###end p 40
###begin p 41
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1359 1361 1359 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1476 1478 1476 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1499 1502 1499 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 2044 2047 2044 2047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 2459 2461 2459 2461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 2462 2464 2462 2464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 2609 2611 2609 2611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 54 69 <span type="species:ncbi:10090">transgenic mice</span>
###xml 892 897 <span type="species:ncbi:9606">human</span>
###xml 1841 1846 <span type="species:ncbi:10090">mouse</span>
###xml 1960 1965 <span type="species:ncbi:9606">human</span>
###xml 2356 2361 <span type="species:ncbi:9606">human</span>
###xml 2366 2371 <span type="species:ncbi:10090">mouse</span>
A recent study reported generation of human BDNF-EGFP transgenic mice using a 145 kb YAC clone including 45 kb of 5' and 33 kb of 3' flanking sequences of hBDNF gene with the protein coding sequence partially replaced with EGFP reporter gene [27]. Three out of five transgenic founder lines obtained in that study expressed transgenic mRNA in the brain and only one of these showed expression of transgenic hBDNF transcripts containing exons IV and VI in the heart. Out of three lines analyzed, EGFP fluorescence was detected in the brain of only one line, specifically in the claustrum, intermediate layer of parietal cortex, pyramidal cell layer of CA3 hippocampal subfield and a population of neurons in the granule cell layer of the dentate gyrus. However, EGFP fluorescence was not detected in other cortical neuron populations and in the CA1 region of hippocampus where rodent and also human BDNF mRNA are expressed [27]. Differences in the tissue- and neuron-specific expression of transgenic hBDNF-EGFP mRNA and protein between the study by Guillemot et al. [27] and this study can be explained with different lengths of the BDNF gene-flanking genomic regions in the transgenic constructs used: the hBDNF-BAC used in the present study contained 39 kb longer 5' and 16 kb shorter 3' genomic regions of hBDNF gene than the reported hBDNF-YAC construct [27]. In addition, part of BDNF coding sequence had been replaced with EGFP reporter gene in the hBDNF-YAC transgene [27], possibly removing cis-elements with regulatory function. In contrast to the present study, hBDNF-YAC transgenic mRNA expression was not analyzed in different brain regions and expression of transgenic mRNAs containing exons III, V, Vh, VII and 5'-extended exon IX was not analyzed. More detailed comparison of hBDNF-EGFP expression in the two hBDNF transgenic mouse models would allow narrowing down genomic regions containing enhancer elements for tissue-specific expression of human BDNF. For example, on the basis of current data it can be hypothesized that a cis-element promoting heart-specific expression of hBDNF mRNA is located within the 3' terminal 16 kb of hBDNF-YAC construct (17-33 kb downstream of the hBDNF gene; chr11:27,600,000-27,616,000; UCSC Genome Browser, Mar 2006 Assembly). Recently, a BDNF regulatory locus has been discovered 850 kb upstream of the human and mouse BDNF genes that causes obesity, cognitive impairment and hyperactivity when disrupted [44,45]. Therefore, it is possible that in addition to regulatory elements included in the hBDNF-BAC of this study and the hBDNF-YAC described before [27], others can be found hundreds of kilobases away from the BDNF gene.
###end p 41
###begin p 42
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1123 1132 1123 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1133 1135 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1136 1138 1136 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1264 1271 1264 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 176 191 <span type="species:ncbi:10090">transgenic mice</span>
###xml 265 270 <span type="species:ncbi:9606">human</span>
###xml 330 335 <span type="species:ncbi:9606">human</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 598 603 <span type="species:ncbi:10090">mouse</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 1248 1263 <span type="species:ncbi:10090">transgenic mice</span>
EGFP reporter gene has been successfully used to visualize BAC-driven expression of neural genes in a number of studies [23-25]. In the BAC construct that was used to generate transgenic mice in the present study, EGFP reporter gene was fused C-terminally with the human BDNF coding sequence to allow detailed characterization of human BDNF expression in the nervous system. Unfortunately, we could not detect EGFP protein in the brain of C3 mice neither with fluorescence microscopy nor with Western blot analysis. This could be explained with low levels of hBDNF-EGFP protein expressed in the C3 mouse brain as transgenic hBDNF-EGFP mRNA levels were about tenfold lower than these of endogenous BDNF. It is also possible that founder mice with higher levels of BDNF-EGFP expression died during embryonic development due to overactivation of BDNF receptor TrkB. This hypothesis is supported by a study showing that embryonic overexpression of BDNF from nestin promoter results in gross abnormalities in brain architecture and perinatal death [46]. Although the hBDNF-EGFP fusion protein can be expressed in cultured cells in vitro [28-30], it is conceivable that it is not translated or has poor translatability and/or stability when expressed in transgenic mice in vivo.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 489 496 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 194 209 <span type="species:ncbi:10090">transgenic mice</span>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 339 344 <span type="species:ncbi:9606">human</span>
###xml 401 416 <span type="species:ncbi:10090">transgenic mice</span>
###xml 473 478 <span type="species:ncbi:9606">human</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
###xml 580 585 <span type="species:ncbi:9606">human</span>
Human genomic region covering 67 kb of the BDNF gene, 84 kb of upstream and 17 kb of downstream sequences is able to drive tissue-specific and kainic acid-induced expression of reporter gene in transgenic mice that largely overlaps with BDNF gene expression and regulation in mouse and human. This is the first study to directly show that human BDNF gene is regulated by neural activity. The BDNF-BAC transgenic mice are useful for studying the transcription regulation of human BDNF gene in vivo. In addition, these mice could be used for screening therapeutic agents modulating human BDNF transcription.
###end p 44
###begin title 45
Methods
###end title 45
###begin title 46
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
Generation of transgenic mice
###end title 46
###begin p 47
###xml 118 121 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 124 128 122 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 156 164 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 442 443 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 849 851 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 156 163 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
BAC clone (RP11-651M4) containing the human BDNF locus [GenBank:] was purchased from Chori BACPAC Resources (USA). Red(R)/ET(R) homologous recombination in E. coli (Counter-Selection BAC Modification Kit, Gene Bridges GmbH, Germany) was used to delete BDNF stop codon and to insert EGFP reporter gene with the linker sequence (CGG GAT CCA CCG GTC GCC ACC) into the 3' end of BDNF. For sequences of primers used for insert synthesis see Table 2. Modified BAC was tested for the absence of rearrangements using EcoRV restriction analysis and pulsed field gel electrophoresis. Integrity of the hBDNF-EGFP reading frame was confirmed by sequencing. In order to validate the reporter activity, BAC DNA was purified using the Large Construct Purification Kit (Qiagen, USA) and transfected into COS-7 cells using DEAE-dextran mediated transfection system [47]. Five days after transfection EGFP expression and distribution in COS-7 cells was visualized using fluorescence microscopy (Eclipse 80i upright microscope, Nikon).
###end p 47
###begin p 48
PCR primers used in this study
###end p 48
###begin p 49
###xml 729 731 725 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1160 1161 1156 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 369 384 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 472 477 <span type="species:ncbi:10090">mouse</span>
###xml 558 562 <span type="species:ncbi:10090">mice</span>
###xml 893 898 <span type="species:ncbi:10090">mouse</span>
hEGFP-BDNF BAC DNA was purified for microinjection by alkaline lysis and linearized with PI-SceI enzyme (NEB, USA). Restriction solution was separated in low-melt agarose gel (Fermentas, Lithuania) using CHEF-DR II Pulsed Field Electrophoresis System (Bio-Rad, USA). Linearized BAC DNA was excised from the gel and purified from agarose using Gelase enzyme (NEB, USA). Transgenic mice were generated by pronuclear injection of linearized hBDNF-EGFP-BAC into CBA x C57Bl/6 mouse pronuclei in the Karolinska Center for Transgene Technologies (Sweden). Founder mice carrying the BAC transgene were identified by PCR analysis of genomic DNA. Transgene copy number was analyzed by slot-blot hybridization of genomic DNA with a [alpha-32P]dCTP-labeled probe generated with HexaLabel DNA Labeling Kit (Fermentas, Lithuania) using pEGFP-N1 (Clontech, USA) plasmid as a template. Genomic DNA of the C3 mouse founder line was analyzed by PCR for the presence of 5' and 3' ends of the linearized transgene. Tandem insertion of transgene into the C3 line genomic DNA was analyzed by PCR with primers pBACe_11326_s or pBACe_11365_s in combination with rp11_3'_s (see Table 2) and sequencing of the PCR product. All animal experiments were performed in agreement with the local Ethical Committee of Animal Experimentation.
###end p 49
###begin title 50
Cell culture, antibodies and animal experiments
###end title 50
###begin p 51
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 702 710 696 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1302 1310 1287 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 0 20 <span type="species:ncbi:9534">African green monkey</span>
###xml 85 89 <span type="species:ncbi:9913">calf</span>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
###xml 351 356 <span type="species:ncbi:10090">mouse</span>
###xml 405 411 <span type="species:ncbi:9986">rabbit</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
###xml 1092 1097 <span type="species:ncbi:10090">mouse</span>
###xml 1262 1266 <span type="species:ncbi:10090">mice</span>
###xml 1283 1287 <span type="species:ncbi:10090">mice</span>
###xml 1341 1346 <span type="species:ncbi:10090">mouse</span>
African green monkey kidney fibroblast COS-7 cells were grown in DMEM with 10% fetal calf serum and antibiotics. Primary neuronal cultures from embryonic day 18 cerebral cortex were prepared as described [48]. For Western blots and immunohistochemistry the following antibodies were used: mouse anti-GFP monoclonal antibodies (Roche Applied Science), mouse anti-GFP monoclonal antibodies (Clontech, USA); rabbit anti-BDNF (Santa Cruz Biotechnology, USA). For kainic acid treatment, adult mice weighing 20-25 g were injected intraperitoneally with 30 mg/kg of kainic acid or 1x PBS. 3 hours later mice were decapitated, hippocampus and cortex dissected, frozen on dry ice and stored at -70degreesC. For in situ hybridization whole brains were embedded in Shandon Cryomatrixtrade mark (Thermo Fisher Scientific, USA). Four kainic acid-treated C3 mice and two control mice were used for quantitative RT-PCR analysis of total hBDNF-EGFP mRNA expression in the cerebral cortex and hippocampus. Total hBDNF-EGFP mRNA was induced 2,5-6 fold in the hippocampus of kainic acid-treated C3 mice and the mouse displaying highest induction of hBDNF-EGFP and mBDNF mRNA was analyzed further with RT-PCR for expression of exon-specific transcripts. Five kainic acid-treated C3 mice and two control mice were used for in situ hybridization analysis and the mouse showing highest induction of hBDNF-EGFP and mBDNF mRNA was further analyzed in more detail.
###end p 51
###begin title 52
RT-PCR
###end title 52
###begin p 53
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">free</italic>
###xml 898 902 898 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
Total RNA was isolated from mouse and human tissues using TRI reagent (Ambion, USA). All experiments with human tissues were approved by the local Ethical Committee for Medical Research. Two mice from each transgenic line were analyzed for tissue-specific expression of hBDNF-EGFP mRNA in brain regions and non-neural tissues and they showed identical transgene expression pattern. RNA was treated with DNase (DNA-free, Ambion, USA) following manufacturer's instructions and five micrograms of total RNA was used for cDNA synthesis with oligo-dT primer (Microsynth, Switzerland) and SuperScript III reverse transcriptase (Invitrogen, USA). PCR amplification was carried out with HotFire DNA polymerase (Solis Biodyne, Estonia) according to the manufacturer's instructions. Quantitative real-time PCR was performed on a LightCycler 2.0 instrument (Roche Applied Science) using qPCR Core kit for SYBR(R) Green I No ROX (Eurogentec, Belgium). Melting curve analysis was carried out at the end of cycling to confirm amplification of a single PCR product. All qPCR reactions were performed in triplicate and normalized to hypoxanthin phosphoribosyltransferase 1 (HPRT1) mRNA levels.
###end p 53
###begin title 54
Ribonuclease protection assay
###end title 54
###begin p 55
###xml 245 247 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 276 285 272 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 415 417 410 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
For cRNA synthesis 624 bp BDNF-EGFP fragment containing 452 bp of BDNF, 21 bp linker sequence and 151 bp of EGFP sequence was amplified with PCR from modified BAC clone RP11-651M4 and cloned into pBluescript SK+ vector (Stratagene, USA). [alpha-32P]UTP-labeled cRNA probe was in vitro transcribed from linearized plasmid template using MAXIscript Kit and T3 polymerase (Ambion, USA). 10 mug of total RNA and 2.5 x105 CPM of radiolabeled probe were used for RPA hybridization and the assay was performed with the RPA III Kit from Ambion as suggested by the manufacturer. The protected fragments were separated in 4% acrylamid-urea gel and detected autoradiographically using BioRad Molecular Imager FX.
###end p 55
###begin title 56
In situ hybridization
###end title 56
###begin p 57
###xml 238 240 234 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 494 496 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 427 432 <span type="species:ncbi:10090">mouse</span>
cRNA probe complementary to the coding region was used to mouse BDNF mRNA and probe complementary to EGFP was used to detect hBDNF mRNA. Probes were synthesized from DNA fragments subcloned into pCR4-TOPO vector (Invitrogen, USA). [alpha-35S]UTP-labeled probes were generated with MAXIScript In Vitro Transcription Kit (Ambion, USA) using linearized DNA template and T3 or T7 RNA polymerase. 16 mum sections of fresh-frozen C3 mouse brain were processed according to the protocol described in [13]. Slides were exposed to either BioMax MR X-ray film for one week or NTB-2 photoemulsion for 2 months, developed with D19 developer and fixed with a general-purpose fixer (all from Eastman Kodak, USA). Slides exposed to NTB-2 were counterstained with hematoxylin (Vector Laboratories Inc., USA).
###end p 57
###begin title 58
Authors' contributions
###end title 58
###begin p 59
###xml 25 40 <span type="species:ncbi:10090">transgenic mice</span>
###xml 210 225 <span type="species:ncbi:10090">transgenic mice</span>
###xml 483 498 <span type="species:ncbi:10090">transgenic mice</span>
###xml 599 604 <span type="species:ncbi:9606">human</span>
IK bred and analyzed the transgenic mice, performed in situ hybridization and RT-PCR analysis. TAP prepared the BAC-BDNF-EGFP construct, carried out transfection experiments and initial characterization of the transgenic mice. KJ performed transgene integration analysis, RT-PCR experiments and contributed to the breeding of founder lines. MS performed RNase protection assay, Western blot analysis and fluorescence microscopy. PP contributed to the initial characterization of the transgenic mice, cultured embryonic neurons and performed in situ hybridization analysis of BDNF mRNA expression in human hippocampus. KP conceived and coordinated the preparation of the transgenic construct. TT conceived and coordinated the study. IK and TT co-wrote the manuscript, all authors contributed to the analysis of the results and preparation of the manuscript. All authors read and approved the final manuscript.
###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
We thank Epp Vali for technical assistance and Enn Joeste and Liina Kiho from North Estonian Regional Hospital, Tallinn, for collaboration. This work was supported by the following grants to TT: Wellcome Trust International Senior Research Fellowship (Grant 067952), Estonian Ministry of Education and Research (Grant 0140143), Estonian Enterprise (Grant EU27553) and Estonian Science Foundation (Grant 7257).
###end p 61
###begin article-title 62
Molecular cloning and expression of brain-derived neurotrophic factor
###end article-title 62
###begin article-title 63
Brain-derived neurotrophic factor
###end article-title 63
###begin article-title 64
Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system
###end article-title 64
###begin article-title 65
BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis
###end article-title 65
###begin article-title 66
Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus
###end article-title 66
###begin article-title 67
Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain
###end article-title 67
###begin article-title 68
###xml 38 41 <span type="species:ncbi:10116">rat</span>
NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression
###end article-title 68
###begin article-title 69
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 13 <span type="species:ncbi:10116">rat</span>
Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations
###end article-title 69
###begin article-title 70
###xml 94 97 <span type="species:ncbi:10116">rat</span>
Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport
###end article-title 70
###begin article-title 71
###xml 53 57 <span type="species:ncbi:10116">rats</span>
Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain
###end article-title 71
###begin article-title 72
###xml 27 30 <span type="species:ncbi:10116">rat</span>
Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family
###end article-title 72
###begin article-title 73
###xml 138 143 <span type="species:ncbi:9606">human</span>
Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues
###end article-title 73
###begin article-title 74
###xml 60 63 <span type="species:ncbi:10116">rat</span>
Multiple promoters direct tissue-specific expression of the rat BDNF gene
###end article-title 74
###begin article-title 75
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 10 13 <span type="species:ncbi:10116">rat</span>
Mouse and rat BDNF gene structure and expression revisited
###end article-title 75
###begin article-title 76
Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine
###end article-title 76
###begin article-title 77
###xml 15 20 <span type="species:ncbi:9606">human</span>
Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters
###end article-title 77
###begin article-title 78
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease
###end article-title 78
###begin article-title 79
Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system
###end article-title 79
###begin article-title 80
###xml 59 62 <span type="species:ncbi:10116">rat</span>
Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors
###end article-title 80
###begin article-title 81
###xml 34 39 <span type="species:ncbi:9606">human</span>
Transcriptional activation of the human brain-derived neurotrophic factor gene promoter III by dopamine signaling in NT2/N neurons
###end article-title 81
###begin article-title 82
Advances in small molecules promoting neurotrophic function
###end article-title 82
###begin article-title 83
###xml 34 49 <span type="species:ncbi:10090">transgenic mice</span>
BAC to the future: the use of bac transgenic mice for neuroscience research
###end article-title 83
###begin article-title 84
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Analysis of cerebellar Purkinje cells using EAAT4 glutamate transporter promoter reporter in mice generated via bacterial artificial chromosome-mediated transgenesis
###end article-title 84
###begin article-title 85
###xml 101 116 <span type="species:ncbi:10090">transgenic mice</span>
Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice
###end article-title 85
###begin article-title 86
###xml 4 19 <span type="species:ncbi:10090">transgenic mice</span>
BAC transgenic mice express enhanced green fluorescent protein in central and peripheral cholinergic neurons
###end article-title 86
###begin article-title 87
###xml 150 165 <span type="species:ncbi:10090">transgenic mice</span>
Identification of brain-derived neurotrophic factor promoter regions mediating tissue-specific, axotomy-, and neuronal activity-induced expression in transgenic mice
###end article-title 87
###begin article-title 88
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo
###end article-title 88
###begin article-title 89
BDNF-GFP containing secretory granules are localized in the vicinity of synaptic junctions of cultured cortical neurons
###end article-title 89
###begin article-title 90
Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses
###end article-title 90
###begin article-title 91
Biological characterization and optical imaging of brain-derived neurotrophic factor-green fluorescent protein suggest an activity-dependent local release of brain-derived neurotrophic factor in neurites of cultured hippocampal neurons
###end article-title 91
###begin article-title 92
Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons
###end article-title 92
###begin article-title 93
###xml 80 85 <span type="species:ncbi:9606">human</span>
BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan
###end article-title 93
###begin article-title 94
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation
###end article-title 94
###begin article-title 95
###xml 101 104 <span type="species:ncbi:10116">rat</span>
Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain
###end article-title 95
###begin article-title 96
Insulators: exploiting transcriptional and epigenetic mechanisms
###end article-title 96
###begin article-title 97
###xml 78 83 <span type="species:ncbi:9606">human</span>
The expression of neurotrophins and their receptors in the prenatal and adult human testis: evidence for functions in Leydig cells
###end article-title 97
###begin article-title 98
Temporal and spatial expression of neurotrophins and their receptors during male germ cell development
###end article-title 98
###begin article-title 99
Calcium regulation of neuronal gene expression
###end article-title 99
###begin article-title 100
From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function
###end article-title 100
###begin article-title 101
Identification of a signaling pathway involved in calcium regulation of BDNF expression
###end article-title 101
###begin article-title 102
Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism
###end article-title 102
###begin article-title 103
A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition
###end article-title 103
###begin article-title 104
###xml 109 112 <span type="species:ncbi:10116">rat</span>
Analysis of transcriptional initiation and translatability of brain-derived neurotrophic factor mRNAs in the rat brain
###end article-title 104
###begin article-title 105
Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene
###end article-title 105
###begin article-title 106
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Disruption of a novel regulatory locus results in decreased Bdnf expression, obesity, and type 2 diabetes in mice
###end article-title 106
###begin article-title 107
BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex
###end article-title 107
###begin article-title 108
DEAE-dextran transfection of mammalian cultured cells
###end article-title 108
###begin article-title 109
###xml 167 171 <span type="species:ncbi:10090">mice</span>
Optimized protocols for the simultaneous preparation of primary neuronal cultures of the neocortex, hippocampus and cerebellum from individual newborn (P0.5) C57Bl/6J mice
###end article-title 109

